Allen Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,020
Closed -$278K 227
2024
Q1
$278K Sell
10,020
-580
-5% -$16.1K ﹤0.01% 191
2023
Q4
$305K Sell
10,600
-1,304
-11% -$39.4K ﹤0.01% 194
2023
Q3
$395K Buy
11,904
+175
+1% +$6.19K 0.01% 181
2023
Q2
$430K Sell
11,729
-5,916
-34% -$230K 0.01% 166
2023
Q1
$720K Buy
17,645
+675
+4% +$29.2K 0.01% 142
2022
Q4
$870K Hold
16,970
0.01% 132
2022
Q3
$743K Hold
16,970
0.01% 135
2022
Q2
$890K Hold
16,970
0.01% 136
2022
Q1
$879K Sell
16,970
-71,970
-81% -$3.73M 0.01% 143
2021
Q4
$5.25M Buy
88,940
+71,970
+424% +$3.57M 0.07% 85
2021
Q3
$730K Hold
16,970
0.01% 124
2021
Q2
$665K Hold
16,970
0.01% 122
2021
Q1
$615K Sell
16,970
-2,966
-15% -$105K 0.01% 129
2020
Q4
$734K Buy
19,936
+47
+0.2% +$1.72K 0.01% 120
2020
Q3
$693K Buy
19,889
+1,319
+7% +$46.2K 0.01% 116
2020
Q2
$576K Hold
18,570
0.01% 120
2020
Q1
$575K Buy
18,570
+4,015
+28% +$137K 0.02% 120
2019
Q4
$541K Sell
14,555
-4,414
-23% -$157K 0.01% 121
2019
Q3
$647K Buy
18,969
+790
+4% +$28.7K 0.02% 127
2019
Q2
$747K Buy
18,179
+1,820
+11% +$72.3K 0.02% 123
2019
Q1
$659K Buy
+16,359
New +$655K 0.02% 122

Other funds holding PFE

Allen Investment Management's PFE Position: Q2 2024 in Review

Allen Investment Management sold out of Pfizer (PFE) in Q2 2024, closing a stake of 10,020 shares — an estimated $278K sold.

Allen Investment Management first reported a position in PFE in Q1 2019 and held it in 21 quarters. The position peaked at $5.25M in Q4 2021. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Allen Investment Management reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
  • Allen Investment Management sold 10,020 Pfizer shares in Q2 2024, an estimated $278K.
  • Allen Investment Management first reported a position in Pfizer in Q1 2019 and held it in 21 quarters.
  • Allen Investment Management's Pfizer position peaked at $5.25M in Q4 2021.
  • 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Allen Investment Management's 13F filing for Q2 2024, filed 8 Aug 2024.